Table 2.

Number of SNV and short insertion/deletion mutations in the sequenced samples

Treatment	n	SNV	Insertion	Deletion
		Mean ± SD	Mean ± SD	Mean ± SD
None (starting clone)	1	0	0	0
Mock	4	47 ± 20	4.5 ± 1.3	3.0 ± 0.8
Cisplatin	3	812 ± 193	49.0 ± 15.0	83.0 ± 21.2
Cyclophosphamide	3	254 ± 50	3.0 ± 1.7	5.0 ± 1.7
Hydroxyurea	3	74 ± 9	4.7 ± 1.5	3.7 ± 1.2
Gemcitabine	3	57 ± 31	2.3 ± 2.1	3.0 ± 1.7
5-fluorouracil	3	50 ± 16	3.0 ± 1.0	2.7 ± 1.5
Etoposide	3	95 ± 15	3.7 ± 1.2	6.7 ± 4.2
Doxorubicin	3	44 ± 15	3.3 ± 0.6	4.0 ± 4.6
Paclitaxel	3	64 ± 10	1.0 ± 1.0	3.0 ± 0.0